<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en">
	<front>
		<journal-meta>
			<journal-id journal-id-type="publisher-id">AJMB</journal-id>
			<journal-title>Avicenna Journal of Medical Biotechnology</journal-title>
			<issn pub-type="ppub">2008-2835</issn>
			<issn pub-type="epub">2008-4625</issn>
			<publisher>
				<publisher-name>Avicenna Research Institute</publisher-name>
			</publisher>
		</journal-meta>
		<article-meta>
			<article-id pub-id-type="publisher-id">AJMB-1-37</article-id>
			<article-categories>
				<subj-group subj-group-type="heading">
					<subject>Original Article</subject>
				</subj-group>
			</article-categories>
			<title-group>
				<article-title>Construction of a High Efficiency PCR Products Cloning T Vector Using pGEM-5zf (+)</article-title>
			</title-group>
			<contrib-group>
				<contrib contrib-type="author">
					<name>
						<surname>Zhao</surname>
						<given-names>Yaofeng</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Liu</surname>
						<given-names>Zhancai</given-names>
					</name>
					<xref ref-type="aff" rid="AF0002">2</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Yu</surname>
						<given-names>Shuyang</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Wen</surname>
						<given-names>Sicheng</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author">
					<name>
						<surname>Hammarstrom</surname>
						<given-names>Lennart</given-names>
					</name>
					<xref ref-type="aff" rid="AF0001">1</xref>
				</contrib>
				<contrib contrib-type="author" corresp="yes">
					<name>
						<surname>Rabbani</surname>
						<given-names>Hodjattallah</given-names>
					</name>
					<xref ref-type="aff" rid="AF0003">3</xref>
					<xref ref-type="aff" rid="AF0004">4</xref>
					<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
				</contrib>
			</contrib-group>
			<aff id="AF0001">
				<label>1</label>Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska University Hospital Huddinge, SE-141 86, Stockholm, Sweden</aff>
			<aff id="AF0002">
				<label>2</label>Department of Physics, Chemistry and Biology, Jiaozuo Teachers College, Jiaozuo, 454001, Henan, P. R. China</aff>
			<aff id="AF0003">
				<label>3</label>Immune and Gene Therapy Laboratory, CCK, Karolinska University Hospital Solna, Stockholm, Sweden</aff>
			<aff id="AF0004">
				<label>4</label>Department of Antigen and Antibody Engineering, Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran</aff>
			<author-notes>
				<corresp id="cor1">
				<label>&#x002A;</label>
					<bold>Corresponding author:</bold> Hodjattallah Rabbani, Ph.D., Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran. P.O. Box: 19615-1177. <bold>Tel:</bold> +98 21 22432020. <bold>Fax:</bold> +98 21 22432021. <bold>E-mail:</bold> <email xlink:href="Hodjattallah.Rabbani@cck.ki.se">Hodjattallah.Rabbani@cck.ki.se</email>
				</corresp>
			</author-notes>
			<pub-date pub-type="ppub">
				<season>April-June</season>
				<year>2009</year>
			</pub-date>
			<volume>1</volume>
			<issue>1</issue>
			<fpage>37</fpage>
			<lpage>39</lpage>
			<history>
				<date date-type="received">
					<day>31</day>
					<month>01</month>
					<year>2009</year>
				</date>
				<date date-type="accepted">
					<day>28</day>
					<month>02</month>
					<year>2009</year>
				</date>
			</history>
			<permissions>
				<copyright-statement>Copyright &#x00A9; 2009 Avicenna Research Institute</copyright-statement>
				<copyright-year>2009</copyright-year>
				<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
					<p>This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.</p>
				</license>
			</permissions>
			<abstract>
					<p>A highly efficient cloning vector was constructed for cloning PCR products by inserting an 80 bp DNA fragment into pGEM-5zf (+) vector. The Xcm I digestion of this vector gave rise to a 3&#x2032; overhanging deoxythymidine offering the possibility of cloning PCR products with 3&#x2032; adenosine overhang created by Taq DNA polymerase. Furthermore, two EcoR I sites were added to the construct for identification of recombinant plasmids using a single restriction enzyme. Taken together, the more efficient cloning performance and the lower cost of this vector as compared to the commercial T vector, suggests that it may be one of the best T vectors for cloning of PCR products.</p>
			</abstract>
			<kwd-group>
				<kwd>Cloning</kwd>
				<kwd>PCR products</kwd>
				<kwd>pGEM-5zf(+)</kwd>
				<kwd>T vector</kwd>
			</kwd-group>
		</article-meta>
	</front>
	<body>
		<sec id="S0001" sec-type="intro">
			<title>Introduction</title>
			<p>Cloning of PCR products has become a standard routine in most molecular biological laboratories.</p>
			<p>The commonly used cloning strategy utilizes the feature of Taq DNA polymerase to add a 3&#x2032; overhanging deoxyadenosine residues in most of the PCR products (<xref ref-type="bibr" rid="CIT0001">1</xref>). Therefore, T vectors possessing two 3&#x2032; overhanging deoxythymidines have been created using different approaches, either by tailing a single deoxythymidine to the 3&#x2032; end of linear and blunt ended plasmids (<xref ref-type="bibr" rid="CIT0002">2</xref>) or by cutting a modified plasmid with selected restriction enzymes such as <italic>Xcm</italic> I, to generate linear plasmids with single overhang deoxythymidine at both 3&#x2032; ends (<xref ref-type="bibr" rid="CIT0003">3</xref>&#x2013;<xref ref-type="bibr" rid="CIT0008">8</xref>). Theoretically, the T vector prepared by utilizing the restriction enzymes should have a higher cloning efficiency than a tailed one. Very often, however, the plasmids are only partially digested by <italic>Xcm</italic> I (<xref ref-type="bibr" rid="CIT0005">5</xref>, <xref ref-type="bibr" rid="CIT0008">8</xref>), probably because the two <italic>Xcm</italic> I recognized sites are usually separated only by a few nucleotides, resulting in a high percentage of non recombinant transformants. Several methods have been employed to circumvent this problem including dephosphorylation of linear T vectors (<xref ref-type="bibr" rid="CIT0004">4</xref>) or introduction of a long spacer between the two <italic>Xcm I</italic> sites in order to make the fully digested vectors easy to recover and purify (<xref ref-type="bibr" rid="CIT0006">6</xref>).</p>
			<p>Furthermore, as the <italic>Xcm</italic> I recognizes 9 random nucleotides between the conserved CCA and TGG sequences, the efficiency of digestion could be increased by alteration of the recognition sequences even using a short spacer between the two <italic>Xcm</italic> I sites. In this paper, we have constructed a very effective T cloning vector based on this idea.</p>
		</sec>
		<sec id="S0002" sec-type="materials|methods">
			<title>Materials and Methods</title>
			<p>An 80 base oligo (5&#x2032; gaagaggcggtcgacgaattcccaaaattaaaatggatcgatcgccatcgaaattttgggaattcactagtgtgccgtcc 3&#x2032;), T-oligo, containing two <italic>Xcm</italic> I sites and two <italic>EcoR</italic> I sites flanked by <italic>Spe</italic> I and <italic>Sal</italic> I sites, was synthesized. To make a double stranded DNA (dsDNA), a PCR was carried out using the T-oligo as a template, and two primers, T-sense (5&#x2032; gaa gca gcg gtc gac gaa tt 3&#x2032;) and T-antisense (5&#x2032; gga cgg cac act agt gaa tt 3&#x2032;) and were designed based on the ends of the T-oligo.</p>
			<p>The PCR conditions were 94<italic>&#x00B0;C</italic>/2 <italic>minutes</italic>, 30 cycles of 94<italic>&#x00B0;C</italic> /10 <italic>second</italic>, 58<italic>&#x00B0;C</italic> /15 <italic>second</italic>, 72<italic>&#x00B0;C</italic> /15 <italic>second</italic>, which yielded a specific amplification and no primer dimers could be detected after running the PCR products on an agarose gel.</p>
			<p>The resulting PCR products were purified with a QIAGEN Gel Extraction Kit (QIAGEN, Valencia, CA, U.S.A), and subsequently digested using <italic>Sal</italic> I and <italic>Spe</italic> I. The restriction reaction was cleaned using QIAGEN Nucleotide Removal Kit. The purified DNA was ligated with <italic>Sal</italic> I and <italic>Spe</italic> I double digested pGEM-5zf(+) and transformed into E.coli DH5&#x3B1; for screening.</p>
		</sec>
		<sec id="S0003" sec-type="results">
			<title>Results</title>
			<p>As designed, insertion of the short oligo into pGEM-5zf(+) did not change the open reading frame of the LacZ gene and therefore the normal LacZ activity was maintained.</p>
			<p>Approximately 90% of the blue clones were recombinants which contained an insertion with the expected sequence, while 10% were self-ligated plasmids, reflecting the fact that plasmids were probably cut only by either <italic>Spe</italic> I or <italic>Sal</italic> I. The recombinant plasmid with the correct insert was named pGEM-FT (Figure 1).</p>
			<fig id="F0001">
				<graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="AJMB-1-37-g001.tif" alt-version="no"/>
			</fig>
			<p>To test the cloning efficiency of the pGEM-FT vector, the plasmids were digested using <italic>Xcm</italic> I at 37<italic>&#x00B0;C</italic> overnight and separated on a 0.7% agarose gel. The linear plasmids were purified with QIAGEN Gel Extraction Kit (QIAGEN, Valencia, CA, U.S.A) and about 70 <italic>ng</italic> of the recovered vectors were ligated with 100 <italic>ng</italic> of an approximately 800 <italic>bp</italic> PCR product (rat Ig C&#x3B4; gene derived), produced by Taq DNA polymerase, using 3 <italic>Units</italic> of T4 DNA ligase. The ligation mixture was transformed into CaCl<sub>2</sub> treated DH5&#x3B1; competent cells. Of a total of 803 transformed clones, 24 (approximately 3%) turned blue under color selection meaning that the pGEM-FT plasmid can be effectively digested by <italic>Xcm</italic> I. Most white clones were recombinants as proven by PCR (17/18), and the purified plasmids could be digested by <italic>Eco</italic>R I, liberating inserts with the expected size, indicating that the pGEM-FT vector digested by <italic>Xcm</italic> I could yield a high cloning efficiency, where more than 90% of transformants contain the correct insert.</p>
			<p>A parallel experiment was also performed to compare the cloning efficacy of the pGEM-FT with the pGEM-T purchased from Promega (Madison, CA, U.S.A), where 60 <italic>ng</italic> of PCR products (263 <italic>bp</italic>, bovine IgE CH4 domain derived) were respectively ligated with 50 <italic>ng</italic> of both the vectors using 3U T4 DNA ligase. After transformation, pGEM-FT yielded totally 120 clones, of which 4 (3.3%) were blue, whereas the commercial pGEM-T yielded 14 blue clones out of 173 (8%), indicating the pGEM-FT produced a higher ratio of recombinants than the pGEM-T. The inserts could be easily released by <italic>Eco</italic>R I from the plasmids purified from all 10 randomly selected white colonies. Furthermore, sequencing analysis showed that the inserts were integrated into the pGEM-FT in the expected way (T/A cloning). However, more cloning experiments also showed that the longer the PCR product the lower the cloning efficacy of the PGEM-FT as seen with other vectors.</p>
		</sec>
		<sec id="S0004" sec-type="discussion">
			<title>Discussion</title>
			<p>In summary, there are several advantages to the cloning of PCR products with pGEM-FT vectors. First of all, the pGEM-FT can be effectively double-digested by <italic>Xcm I</italic> to produce a highly efficient PCR cloning T vector, which offers up to 97% recombinant transformants under color selection. The high background of non-recombinant transformants, which is frequently encountered using restriction endonuclease digested T vectors, is therefore largely reduced. Furthermore, the addition of two <italic>Eco</italic>R I sites to the plasmid allows the identification of recombinant plasmids using a single, cheap restriction enzyme. Taken together, the even better cloning performance and the lower cost of the pGEM-FT vector as compared to the commercial T vector, suggests that it may be one of the best T vectors for cloning of PCR products.</p>
		</sec>
	</body>
	<back>
		<ref-list>
			<title>References</title>
			<ref id="CIT0001">
				<label>1</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Clark</surname>
							<given-names>JM</given-names>
						</name>
					</person-group>
					<article-title>Novel non-templated nucleotide addition reactions catalyzed by procaryotic and eucaryotic DNA polymerases</article-title>
					<source>Nucleic Acids Res</source>
					<year>1988</year>
					<volume>16</volume>
					<issue>20</issue>
					<fpage>9677</fpage>
					<lpage>9686</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0002">
				<label>2</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Holton</surname>
							<given-names>TA</given-names>
						</name>
						<name>
							<surname>Graham</surname>
							<given-names>MW</given-names>
						</name>
					</person-group>
					<article-title>A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors</article-title>
					<source>Nucleic Acids Res</source>
					<year>1991</year>
					<volume>19</volume>
					<issue>5</issue>
					<fpage>1156</fpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0003">
				<label>3</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Borovkov</surname>
							<given-names>AY</given-names>
						</name>
						<name>
							<surname>Rivkin</surname>
							<given-names>MI</given-names>
						</name>
					</person-group>
					<article-title>XcmI-containing vector for direct cloning of PCR products</article-title>
					<source>Biotechniques</source>
					<year>1997</year>
					<volume>22</volume>
					<issue>5</issue>
					<fpage>812</fpage>
					<lpage>814</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0004">
				<label>4</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Cha</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Bishai</surname>
							<given-names>W</given-names>
						</name>
						<name>
							<surname>Chandrasegaran</surname>
							<given-names>S</given-names>
						</name>
					</person-group>
					<article-title>New vectors for direct cloning of PCR products</article-title>
					<source>Gene</source>
					<year>1993</year>
					<volume>136</volume>
					<issue>1&#x2013;2</issue>
					<fpage>369</fpage>
					<lpage>370</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0005">
				<label>5</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Harrison</surname>
							<given-names>J</given-names>
						</name>
						<name>
							<surname>Molloy</surname>
							<given-names>PL</given-names>
						</name>
						<name>
							<surname>Clark</surname>
							<given-names>SJ</given-names>
						</name>
					</person-group>
					<article-title>Direct cloning of polymerase chain reaction products in an XcmI T- vector</article-title>
					<source>Anal Biochem</source>
					<year>1994</year>
					<volume>216</volume>
					<issue>1</issue>
					<fpage>235</fpage>
					<lpage>236</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0006">
				<label>6</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Jo</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Jo</surname>
							<given-names>SA</given-names>
						</name>
					</person-group>
					<article-title>A simple method to construct T-vectors using Xcm I cassettes amplified by nonspecific PCR</article-title>
					<source>Plasmid</source>
					<year>2001</year>
					<volume>45</volume>
					<issue>1</issue>
					<fpage>37</fpage>
					<lpage>40</lpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0007">
				<label>7</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Kovalic</surname>
							<given-names>DJ</given-names>
						</name>
						<name>
							<surname>Kwak</surname>
							<given-names>H</given-names>
						</name>
						<name>
							<surname>Weisblum</surname>
							<given-names>B</given-names>
						</name>
					</person-group>
					<article-title>General method for direct cloning of DNA fragments generated by the polymerase chain reaction</article-title>
					<source>Nucleic Acids Res</source>
					<year>1991</year>
					<volume>19</volume>
					<issue>16</issue>
					<fpage>4560</fpage>
				</nlm-citation>
			</ref>
			<ref id="CIT0008">
				<label>8</label>
				<nlm-citation citation-type="journal">
					<person-group person-group-type="author">
						<name>
							<surname>Mead</surname>
							<given-names>DA</given-names>
						</name>
						<name>
							<surname>Pey</surname>
							<given-names>NK</given-names>
						</name>
						<name>
							<surname>Herrnstadt</surname>
							<given-names>C</given-names>
						</name>
						<name>
							<surname>Marcil</surname>
							<given-names>RA</given-names>
						</name>
						<name>
							<surname>Smith</surname>
							<given-names>LM</given-names>
						</name>
					</person-group>
					<article-title>A universal method for the direct cloning of PCR amplified nucleic acid</article-title>
					<source>Biotechnology</source>
					<year>1991</year>
					<volume>9</volume>
					<issue>7</issue>
					<fpage>657</fpage>
					<lpage>663</lpage>
				</nlm-citation>
			</ref>
		</ref-list>
	</back>
</article>
